Sabinsa Gains U.S. Patent for Cococin™

PISCATAWAY, N.J.—Sabinsa Corp. was awarded a new U.S. patent (No. 7,300,682), “Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance.” The patent covers the derivation process, composition and intended uses of Sabinsa’s branded ingredient Cococin™, a freeze-dried powder form of green coconut water.

“Coconut water’s staggering levels of active ingredients provides an exceptionally rich repository of vitamins, minerals and amino, shikimic and quinic acids essential for healthy tissue growth, resulting in an optimal ingredient for today’s cosmeceutical market,” said Lakshmi Prakash, Ph.D., vice president of innovation and business development at Sabinsa. “We have worked diligently to secure this process, composition and use patent to ensure a safe and efficacious ingredient resulting from Sabinsa’s high-quality, nutrient-preserving freeze drying process.”

In addition to the new U.S. patent, Cococin is covered by a European Patent (No. EP1341547) for its process, composition and use in the European market.